Lenograstim

• Immune support suring times of: Seasonal colds and flu

Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be disoolved into a little water

Stop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children.

Recent PubMed references pinned to Lenograstim as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience.
  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2021 · Sarıcı A, Erkurt MA, Bahçecioğlu ÖF, et al.
  PMID 33863669DOI 10.1016/j.transci.2021.103127
• Lenograstim-Induced Nodal Extramedullary Hematopoiesis: A Challenging Diagnosis in Lymphoma Evaluation With 18F-FDG PET/CT.
  Clinical nuclear medicine · 2020 · Leroy-Freschini B, Nicolae A, Iltis-Roux A, et al.
  PMID 32558708DOI 10.1097/RLU.0000000000003111
• Intrauterine G-CSF Administration in Recurrent Implantation Failure (RIF): An Rct.
  Scientific reports · 2020 · Kalem Z, Namli Kalem M, Bakirarar B, et al.
  PMID 32198409DOI 10.1038/s41598-020-61955-7
• Recurrent pregnancy-induced agranulocytosis; case report and literature review.
  British journal of haematology · 2020 · Ahmed MZ, Murthy V, Shenouda A, et al.
  PMID 31743422DOI 10.1111/bjh.16269
• Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats.
  BioMed research international · 2019 · Papalois AE, Barbatis C, Chrysikos D, et al.
  PMID 31687401DOI 10.1155/2019/8298192
• Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
  Transfusion · 2019 · Kang J, Hong JY, Yoon DH, et al.
  PMID 30924165DOI 10.1111/trf.15265
• Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
  Transfusion · 2018 · Marchesi F, Vacca M, Giannarelli D, et al.
  PMID 29446445DOI 10.1111/trf.14533
• Pyoderma gangrenosum on G-CSF (lenograstim) treatment during pregnancy.
  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2017 · Weiß KT, Berneburg M, Santjohanser C, et al.
  PMID 28591456DOI 10.1111/ddg.13245

The 10 most recently updated of 1,716 ClinicalTrials.gov registrations naming Lenograstim as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
  Recruiting · Phase 1 · Interventional · 47 enrolled · National Cancer Institute (NCI)
  NCT07012044updated 2026-06-12
• A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
  Recruiting · Phase 3 · Interventional · 1,023 enrolled · Merck Sharp & Dohme LLC
  NCT07216703updated 2026-06-12
• Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
  Recruiting · Phase 2 · Interventional · 40 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT02015013updated 2026-06-12
• Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
  Recruiting · Phase 2 · Phase 3 · Interventional · 131 enrolled · National Cancer Institute (NCI)
  NCT04628767updated 2026-06-11
• Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
  Recruiting · Phase 1 · Interventional · 4 enrolled · M.D. Anderson Cancer Center
  NCT06414889updated 2026-06-11
• Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
  Recruiting · Phase 1 · Phase 2 · Interventional · 10 enrolled · National Institute of Allergy and Infectious Diseases (NIAID)
  NCT06325709updated 2026-06-11
• Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
  Recruiting · Phase 1 · Phase 2 · Interventional · 320 enrolled · National Cancer Institute (NCI)
  NCT04959175updated 2026-06-11
• The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
  Recruiting · Phase 1 · Phase 2 · Interventional · 260 enrolled · National Cancer Institute (NCI)
  NCT05436418updated 2026-06-11
• VA-CAG Two-Week vs. Three-Week Regimen for Induction Remission in Newly Diagnosed Acute Myeloid Leukemia.
  Not yet recruiting · Phase 2 · Interventional · 110 enrolled · Hematology department of the 920th hospital
  NCT07642453updated 2026-06-11
• Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
  Active not recruiting · Phase 1 · Phase 2 · Interventional · 74 enrolled · M.D. Anderson Cancer Center
  NCT03247088updated 2026-06-10

Frequently asked questions

What is Lenograstim used for?

According to FDA labeling, Lenograstim carries indications including: Immune support suring times of: Seasonal colds and flu. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What class of drug is Lenograstim?

Lenograstim is classified as Colony stimulating factors.